These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 5897860

  • 1. [Significance of the mycobacterial resistance to antitubercular agents in the therapeutic results of treatments of polyresistant patients].
    Jancik E, Novák M, Feitová S, Jan ciková M, Tousek J.
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):325-8. PubMed ID: 5897860
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Comparative study on rifomycin in resumption of treatment of pulmonary tuberculosis cases with polyresistant bacilli].
    Prignot J, Gyselen A, Cosemans J, De Brabandere R, Verbist L, Simon-Pouthier F.
    Acta Tuberc Pneumol Belg; 1969 Jul; 60(3):487-95. PubMed ID: 4906102
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Mycobacterial resistance/found in the province of Matera (observations in the 4-year period, 1977-1980)].
    Buono L, Mazzarone R.
    Arch Monaldi; 1981 Jul; 36(3):131-40. PubMed ID: 6816184
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical limits of microbial resistance to secondary antitubercular agents].
    Sakurai H, Hashimoto T.
    Saishin Igaku; 1966 Jan; 21(1):88-94. PubMed ID: 5965948
    [No Abstract] [Full Text] [Related]

  • 9. [Significance of mycobacterial drug resistance in pulmonary tuberculosis surgery].
    Repin IuM, Avetisian AO, El'kin AV, Otten TF, Riasnianskaia TE, Trofimov MA.
    Probl Tuberk; 2001 Jan; (9):6-10. PubMed ID: 11858098
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Results of antibacterial treatment of pulmonary tuberculosis in patients with primary resistance to drugs].
    Mysakowska H, Pietroń E, Sikora-Rózyńska M, Smaga M, Litwin B, Rybicka-Stryjecka Z.
    Pol Tyg Lek; 1965 May 10; 20(19):686-8. PubMed ID: 5844021
    [No Abstract] [Full Text] [Related]

  • 12. [Primary drug-resistance to principal antitubercular agents used in children].
    Bujko K, Zapaśnik-Kobierska MH, Maliszewska Z, Kostrzeński W.
    Pediatr Pol; 1965 Aug 10; 40(8):773-80. PubMed ID: 5294914
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Capreomycin. Therapeutic trial with patients with advanced chronic polyresistant pulmonary tuberculosis].
    Rey JC, González Montaner LJ, Cetrángolo A, Iannello JA.
    Prensa Med Argent; 1967 Jun 16; 54(16):731-5. PubMed ID: 5614108
    [No Abstract] [Full Text] [Related]

  • 15. [Current views on treatment of tuberculosis. Symposium (VI). Current resistance problems in Uppsala patients].
    Hillerdal O.
    Lakartidningen; 1966 May 04; 63(18):1757-8. PubMed ID: 5917520
    [No Abstract] [Full Text] [Related]

  • 16. [Therapeutic difficulties encountered in cases of lung tuberculosis treated with drugs].
    Wilczyński J, Paździor E.
    Pneumonol Pol; 1977 Feb 04; 45(2):141-4. PubMed ID: 840726
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Causes of the emergence of drug resistance and results of the treatment of tuberculous patients at the Torzym Sanatorium].
    Ryszewski W.
    Gruzlica; 1965 Apr 04; 33(4):277-85. PubMed ID: 5319980
    [No Abstract] [Full Text] [Related]

  • 19. [Study on the re-treatment of pulmonary tuberculosis with special reference to resistance to primary drugs].
    Kaku R.
    Kekkaku; 1968 Dec 04; 43(12):520-1. PubMed ID: 5716117
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.